MOH — authorised 27 April 1955
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: likely_approved
🇮🇱 Solu-Cortef in Israel
MOH authorised Solu-Cortef on 27 April 1955
Marketing authorisation
Solu-Cortef in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Solu-Cortef approved in Israel?
Yes. MOH authorised it on 27 April 1955.
Who is the marketing authorisation holder for Solu-Cortef in Israel?
PHARMACIA AND UPJOHN holds the Israeli marketing authorisation.